These Are a Few of Our Favorite IoT: NIST Finalizes Internet of Things Cyber Guidance
Client Alert | 1 min read | 07.02.19
NIST has finalized Internet of Things (IoT) risk management guidance, which derived from a draft publication. The guidance informs government agencies how to understand and manage IoT risks throughout device lifecycles. Industry can anticipate government focus on three high-level goals:
- Device security;
- Data security; and
- Individual privacy.
The publication highlights three differences between managing risks for IoT devices and conventional information technology devices:
- IoT devices interact with the physical world differently than conventional devices;
- IoT devices cannot be accessed and monitored the same as conventional devices; and
- The availability and effectiveness of cybersecurity and privacy capabilities are different for IoT devices than conventional devices.
While not mandatory, the guidance provides useful considerations for IoT cybersecurity and privacy risk management.
Insights
Client Alert | 2 min read | 05.09.25
FDA Seeks Stakeholder Consultation on Prescription Drug User Fee Reauthorization
On May 8, the U.S. Food and Drug Administration (FDA) took steps to begin the process for reauthorizing the Prescription Drug User Fee Amendments (PDUFA) by announcing a public meeting to be held on July 14, 2025. The agency invited public stakeholders, including patient and consumer advocate groups, health care professionals, and scientific and academic experts to participate in the meeting and subsequent public meetings to consult on the PDUFA reauthorization.
Client Alert | 2 min read | 05.09.25
New SF-328 for Foreign Ownership, Control, and Influence Assessments Approved, Publication Imminent
Client Alert | 4 min read | 05.08.25
Client Alert | 4 min read | 05.07.25
